Načítá se...
Nordihydroguaiaretic Acid, a Cytotoxic IGF-IR/HER2 Inhibitor in Trastuzumab-Resistant Breast Cancer
The majority of patients with HER2-overexpressing metastatic breast cancer who initially respond to the HER2-targeted antibody trastuzumab demonstrate disease progression within one year. The identification of novel agents that effectively inhibit survival of cancer cells that have progressed on tra...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2586607/ https://ncbi.nlm.nih.gov/pubmed/18645000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-08-0012 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|